Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on June 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Citrix Server Migration & Configuration for CDS Platforms

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541512
New
Utilization Management Technical Solutions RFI
Solicitation # utilization-management-technical-solutions-rfi
Noridian Healthcare Solutions, LLC is issuing a Request for Information (RFI) to identify qualified technology providers and strategic partners capable of delivering configurable technical solutions for end-to-end utilization management (UM) workflows. The primary objective is to modernize the evaluation of medical necessity, appropriateness of care, provider compliance, and program integrity for federal and state healthcare programs. The scope of the RFI covers a wide range of capabilities, including clinical operations such as intake, prior authorization, and appeals, as well as workflow automation, provider engagement portals, data interoperability using HL7, FHIR, and X12 standards, and the integration of AI and advanced intelligence. This opportunity is open to a broad range of small business entities, including SDB, WOSB, HUBZone, VOSB, and SDVOSB certifications, under NAICS code 541512. Interested respondents must notify Noridian via email to gain access to the Agiloft Contract Management System, where all official correspondence and submissions must be conducted. Responses are required to be submitted using a specific templated spreadsheet by September 21, 2026. Following a comprehensive review of the submissions, Noridian may invite selected respondents to participate in solution demonstrations during the fourth quarter of 2026. Respondents must certify that they are not debarred or suspended and have no conflicts of interest that would prohibit contracting with Noridian.
Noridian Healthcare Solutions, LLC

POSTED

about 9 hours ago

DEADLINE

in 10 days
NAICS: 541512
New
Federal
W912DY26RA030 OFFICIAL SOLICITATION_ AMENDMENT 2 FOR UTILITY MONITORING AND CONTROL SYSTEMS VI
Solicitation # W912DY26RA030
Solicitation W912DY26RA030 is a sealed bid for the Utility Monitoring and Control Systems (UMCS) VI Multiple Award Task Order Contract (MATOC), issued by the U.S. Army Corps of Engineers, Huntsville Engineering and Support Center. The contract seeks qualified contractors to provide procurement, installation, and maintenance and service support for Facility Related Control Systems (FRCS), including HVAC, SCADA, fire alarm, electronic security, and utility metering systems for U.S. Army and Department of Defense facilities. This MATOC features a seven-year ordering period with an aggregate capacity of 5.1 billion dollars shared among all awardees. The scope includes both domestic and OCONUS performance across the European, Pacific, MidEast, and Caribbean regions. Award eligibility is based on a qualifying offer approach where offerors must be determined as responsible sources and receive an Acceptable rating across three evaluation factors: Technical/Management Approach, Past Performance, and Small Business Participation. Price is not evaluated for the base MATOC award but will be a factor for individual task orders. Proposals must be submitted electronically via the Procurement Integrated Enterprise Environment (PIEE) by July 25, 2026, organized into four specific volumes with strict page limits for technical and small business plans. Key requirements include the ability to obtain Secret security clearances, compliance with the National Industrial Security Program Operating Manual, and the submission of a Small Business Participation Plan.
W2V6 USA Engineering Spt Ctr Huntsvil

POSTED

about 13 hours ago

DEADLINE

in 6 days

AI Contract Overview

Show more

The contract involves migrating and configuring Citrix Virtual Delivery Agent (VDA) servers from Windows Server 2016 to Windows Server 2019 to enable support for Empower 3.6.1 and NuGenesis 9.1 CDS applications used across FDA laboratory sites. The work will be performed as a subcontract with a focus on ensuring the upgraded environment is fully compatible with these critical laboratory software platforms. This migration effort is essential to maintain and enhance operational efficiency within the FDA's laboratory infrastructure. The contract is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The place of performance is located in Detroit, ZIP code 48207. The solicitation was posted on June 3, 2026, with a response deadline of June 18, 2026. The relevant industry classification code for this engagement is NAICS 541512, which covers computer systems design services. This effort supports the ongoing modernization of the FDA’s technological environment in laboratory settings.

General Info

Migrate and configure Citrix VDA servers to Windows Server 2019 for FDA lab software support.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541512 - Computer Systems Design ServicesView NAICS

Place of Performance

Detroit, MI, 48207, USA

Set-Aside

NONE

Documents

This scope was carved out of FDA-75F40126Q00166.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Citrix Server Upgrade

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Migrate and configure Citrix VDA servers from Windows Server 2016 to 2019 to support Empower 3.6.1 and NuGenesis 9.1 CDS applications across FDA laboratory sites.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human induced pluripotent stem cell (iPSC)-derived hindbrain organoid functional assay services. The project aims to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits over an eighteen-month period of performance. The scope of work is divided into two primary components: the provision of human hindbrain organoids and associated culture materials through twelve scheduled deliveries to the FDA White Oak Campus, and the performance of functional characterization services at the contractor's laboratory. Functional characterization will utilize three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Deliverables include the delivery of 96 organoids in the first shipment followed by 48 organoids in subsequent deliveries, as well as raw data, analyzed data, analysis files, and comprehensive study reports. This acquisition is conducted as a commercial service under FAR Part 12, with the government restricting competition based on market research identifying OrganoTherapeutics SARL as the only source capable of meeting the complete requirement for both the specific organoid products and the associated functional assay services.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS